AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.

Highlights,Gevo develops sustainable fuels as an alternative to traditional energy sources.,HC Wainwright set a $14.00 target, while UBS Group raised its estimate to $3.25.,Major investors, including ...

Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.

Gevo (NASDAQ:GEVO – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They presently have ...

Investors and other persons interested in learning more about the virtual investor presentation can find information and registration details at the following link: About Gevo Gevo is a ...

Gevo , Inc. (NASDAQ:GEVO), currently trading at $1.86 with a market capitalization of $430 million, retained a positive outlook from H.C. Wainwright, with analyst Amit Dayal reiterating a Buy rating ...

Gevo, Inc. (NASDAQ: GEVO) has successfully completed the acquisition of assets from Red Trail Energy, LLC, including an ethanol production plant and carbon capture and sequestration assets in ...

Gevo, Inc. (NASDAQ: GEVO) has completed the acquisition of Red Trail Energy, LLC's ethanol production plant, carbon capture ...

Gevo said it agreed to acquire the ethanol production plant and carbon capture and sequestration assets of Red Trail Energy ...